Skip to main content

News & Events

News & Announcements

Governor Larry Hogan Kicks Off Israel Trade Mission, Highlights Israeli Biotech Growth in Maryland

VAYA Pharma Recently Moved U.S. Headquarters to University of Maryland BioPark

ANNAPOLIS, MD – Sept. 20, 2016  – Governor Larry Hogan today arrived in Tel Aviv, Israel launching a weeklong economic development mission in the country. The governor is joined by a delegation of state officials, business executives, higher education officials and Jewish community leaders. During the trade mission, the governor will meet with numerous companies and elected officials in an effort to strengthen cultural ties and promote Maryland as a gateway for Israeli companies seeking to establish U.S. operations.

Today, Governor Hogan met with executives at Enzymotec and its subsidiary VAYA Pharma, which recently relocated its U.S. headquarters to the University of Maryland BioPark. With more than 85 employees, VAYA Pharma is an innovator of lipid-based medical foods that are used to manage nutritional imbalances associated with certain diseases and health conditions. VAYA Pharma has a year-over-year growth rate of more than 83 percent with net revenues of $3.4 million in the second quarter of 2016. Steven Dubin, former CEO of Martek Biosciences and a member of the Maryland delegation, is chairman of Enzymotec’s board of directors.

Click here to read the rest of the press release.